Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I study of to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of azidothymidine and colistin alone and in combination for urinary tract infections.

Trial Profile

Phase I study of to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of azidothymidine and colistin alone and in combination for urinary tract infections.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Apr 2018

At a glance

  • Drugs Colistin (Primary) ; Colistin/zidovudine (Primary) ; Zidovudine (Primary)
  • Indications Urinary tract infections
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Apr 2018 New trial record
    • 24 Apr 2018 Results (n=27) presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases.
    • 19 Apr 2018 According to the Helperby Therapeutics media release, data from this study presented at the European Congress of Clinical Microbiology and Infectious Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top